US Patent Issued to SYLUS on March 18 for "Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species" (South Korean Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,523, issued on March 18, was assigned to SYLUS Co. LTD. (Jeonju-si, South Korea).

"Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species" was invented by Che il Moon (Daegu, South Korea), Seung Jun Yoo (Gyeongsan-si, South Korea), Chang-Hun Lee (Daegu, South Korea), So Yeon Kim (Daegu, South Korea) and Deok Ho Lee (Ansan-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A peptide is described herein that has: (i) a simple structure compared to existing natural human erythropoietin, thus capable of easily passing through a tissue-blood barrier, (ii) excellent bioactivity...